| Gene symbol | TNFSF10 | Synonyms | APO2L, Apo-2L, CD253, TANCR, TL2, TNLG6A, TRAIL | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3q26.31 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | TNF superfamily member 10 | ||||
| GTO ID | GTC1322 |
| Trial ID | NCT00923390 |
| Disease | Renal Carcinoma | Kidney Cancer |
| Altered gene | TRAIL |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | 2G-1 TCR-T cells |
| Phase | Phase1 |
| Recruitment status | Terminated |
| Title | Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 Receptor |
| Year | 2009 |
| Country | United States |
| Company sponsor | National Cancer Institute (NCI) |
| Other ID(s) | 090092|09-C-0092 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||